Use and Waste of Reconstituted Whole Blood Exchange Transfusions: An 11-year National Observational Study.

Autor: de Winter DP; Division of Neonatology, Department of Pediatrics, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, the Netherlands; Division of Fetal Medicine, Department of Obstetrics, Leiden University Medical Center, Leiden, the Netherlands; Department of Immunohematology Diagnostic Services, Sanquin Diagnostic Services, Amsterdam, the Netherlands. Electronic address: d.p.de_winter@lumc.nl., Lopriore E; Division of Neonatology, Department of Pediatrics, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, the Netherlands., Hulzebos CV; Division of Neonatology, Department of Pediatrics, Beatrix Children's Hospital, University Medical Center Groningen, Groningen, the Netherlands., Lukens MV; Laboratory for Blood Transfusion, Department of Laboratory Medicine, University Medical Center Groningen, Groningen, the Netherlands., Klinkspoor JHH; Central Diagnostic Laboratory, Amsterdam University Medical Center, Amsterdam, the Netherlands., van Bohemen M; Department of Clinical Chemistry, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands., den Besten G; Department of Clinical Chemistry, Isala, Zwolle, the Netherlands., de Vooght KMK; Central Diagnostics Laboratory, UMC Utrecht, Utrecht, the Netherlands., Vrancken SLAG; Department of Neonatology, Radboud UMC, Amalia Children's Hospital, Nijmegen, the Netherlands., Trompenaars AMP; Division of Neonatology, Department of Pediatrics, MosaKids Children's Hospital, Maastricht University Medical Center, Maastricht, the Netherlands., Hoffmann-Haringsma A; Department of Pediatrics, Franciscus Gasthuis & Vlietland, Rotterdam, the Netherlands., Péquériaux NCVN; Department of Clinical Chemistry and Hematology, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands., Andriessen P; Department of Neonatology, Máxima Medical Center, Veldhoven, the Netherlands., Gijzen K; Department of Clinical Chemistry and Hematology, Meander Medical Center, Amersfoort, the Netherlands., van Hillegersberg JLAMJ; Department of Pediatrics, Sint Antonius Ziekenhuis, Nieuwegein, the Netherlands., Zant JC; Department of Clinical Chemistry, Northwest Clinics, Alkmaar and Den Helder, the Netherlands., van Rossem MC; Department of Pediatrics, Rijnstate, Arnhem, the Netherlands., van Gammeren AJA; Department of Clinical Chemistry and Hematology, Amphia Hospital, Breda, the Netherlands., Weerkamp F; Department of Clinical Chemistry, Maasstadziekenhuis, Rotterdam, the Netherlands., Counsilman CE; Department of Pediatrics, Flevoziekenhuis, Almere, the Netherlands., Knol FRR; Department of Pediatrics, Medisch Centrum Leeuwarden, Leeuwarden, the Netherlands., Schiering IAMI; Department of Pediatrics, Spaarne Gasthuis, Haarlem/Hoofddorp, the Netherlands., Dubbink-Verheij GH; Department of Pediatrics, Groene Hart Ziekenhuis, Gouda, the Netherlands., Verweij EJTJ; Division of Fetal Medicine, Department of Obstetrics, Leiden University Medical Center, Leiden, the Netherlands., de Haas M; Department of Immunohematology Diagnostic Services, Sanquin Diagnostic Services, Amsterdam, the Netherlands; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands.

Publikováno v: The Journal of pediatrics [J Pediatr] 2024 Dec; Vol. 275, pp. 114225. Date of Electronic Publication: 2024 Jul 31.

Fluctuations in Thyroid Hormone Levels During Initial Treatment for Differentiated Thyroid Carcinoma are Associated with Changes in Hemostasis: A Prospective Cohort Study.

Autor: Links MH; Division of Endocrinology, Department of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlands., Lefrandt JD; Division of Vascular Medicine, Department of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlands., Lisman T; Surgical Research Laboratory, Department of Surgery, University Medical Center Groningen, Groningen, The Netherlands., van der Boom T; Division of Endocrinology, Department of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlands., Lukens MV; Department of Laboratory Medicine, University Medical Center Groningen, Groningen, The Netherlands., Meijer K; Department of Hematology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Links TP; Division of Endocrinology, Department of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlands., Zandee WT; Division of Endocrinology, Department of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlands.

Publikováno v: Thyroid : official journal of the American Thyroid Association [Thyroid] 2023 Feb; Vol. 33 (2), pp. 203-213. Date of Electronic Publication: 2022 Dec 13.

Anti-IFC antibodies in a patient with CHAPLE syndrome: Implications for blood management.

Autor: Minović I; Department of Laboratory Medicine, University Medical Center Groningen, Groningen, the Netherlands., Schipperus MR; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands., Mäkelburg ABU; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands., Meijer K; Department of Laboratory Medicine, University Medical Center Groningen, Groningen, the Netherlands., Lukens MV; Department of Laboratory Medicine, University Medical Center Groningen, Groningen, the Netherlands., Kootstra-Ros JE; Department of Laboratory Medicine, University Medical Center Groningen, Groningen, the Netherlands., van der Heide F; Department of Gastroenterology and Hepatology, University Medical Center Groningen, Groningen, the Netherlands., Abbasova I; Department of Anesthesiology, University Medical Center Groningen, Groningen, the Netherlands., de Kleine RHJ; Department of Surgery, University Medical Center Groningen, Groningen, the Netherlands., Meekers JH; Department of Laboratory Medicine, University Medical Center Groningen, Groningen, the Netherlands., Mulder AB; Department of Laboratory Medicine, University Medical Center Groningen, Groningen, the Netherlands.

Publikováno v: British journal of haematology [Br J Haematol] 2023 Jan; Vol. 200 (1), pp. 109-112. Date of Electronic Publication: 2022 Oct 10.

Trough anti-Xa activity after intermediate dose nadroparin for thrombosis prophylaxis in critically ill patients with COVID-19 and acute kidney injury.

Autor: Eck RJ; Department of Internal Medicine, University Medical Center Groningen, University of Groningen, P.O. Box 30.001, 9700 RB, Groningen, The Netherlands. r.j.eck@umcg.nl., van de Leur JJCM; Department of Laboratory Medicine and Thrombosis Expertise Centre, Isala, Zwolle, The Netherlands., Wiersema R; Department of Critical Care, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Cox EGM; Department of Critical Care, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Bult W; Department of Critical Care, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, The Netherlands., Spanjersberg AJ; Department of Anesthesiology and Intensive Care, Isala, Zwolle, The Netherlands., van der Horst ICC; Department of Intensive Care, Maastricht University Medical Center+, Maastricht, The Netherlands.; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands., Lukens MV; Department of Laboratory Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Gans ROB; Department of Internal Medicine, University Medical Center Groningen, University of Groningen, P.O. Box 30.001, 9700 RB, Groningen, The Netherlands., Meijer K; Department of Haematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Keus F; Department of Critical Care, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Publikováno v: Scientific reports [Sci Rep] 2022 Oct 18; Vol. 12 (1), pp. 17408. Date of Electronic Publication: 2022 Oct 18.

Impact of COVID-19 pandemic on the quality of test output in haemostasis laboratories.

Autor: Arisz RA; Department of Hematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands., Meijer P; ECAT Foundation (External quality Control for Assays and Tests), Voorschoten, Netherlands., Péquériaux NCV; Department of Clinical Chemistry and Hematology, Jeroen Bosch Hospital, 's-Hertogenbosch, Netherlands., van de Leur SJ; Department of Clinical Chemistry, Isala Hospital, Zwolle, Netherlands., Lukens MV; Department of Laboratory Medicine, University Medical Center Groningen, University of Groningen, Groningen, Netherlands., de Maat MPM; Department of Hematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands., Hollestelle MJ; ECAT Foundation (External quality Control for Assays and Tests), Voorschoten, Netherlands.

Publikováno v: International journal of laboratory hematology [Int J Lab Hematol] 2022 Apr; Vol. 44 (2), pp. 407-413. Date of Electronic Publication: 2021 Nov 22.